Research directory

Clinical trials

Find trials by company, ticker, title or NCT ID.

Filters
Reset
1,647 trials match your filters.
TrialSponsorPhaseStatusPrimary completion
Study of ARO-APOC3 in Adults With DyslipidemiaNCT05413135Arrowhead PharmaceuticalsPhase 2Completed2025-09-22Actual
Efficacy and Safety of Intravenous Efzofitimod in Patients With Pulmonary SarcoidosisNCT05415137ATYRPhase 3Completed2025-06-25Actual
Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH)NCT05416307ETRAPhase 2, Phase 3Recruiting2027-06Estimated
Pilot Decentralized TrialNCT05419869Alto NeurosciencePhase 2Completed2023-01-13Actual
A Clinical Trial to Evaluate the Safety and Efficacy of Rreproxalap in Adults With Dry Eye DiseaseNCT05424549ALDXPhase 2Completed2022-05-09Actual
Study of XL092 + Atezolizumab vs Regorafenib in Participants With Metastatic Colorectal CancerNCT05425940ExelixisPhase 3Active not recruiting2026-06-16Actual
A Study of Cytisinicline for Vaping Cessation in Adult SmokersNCT05431387Achieve Life SciencesPhase 2Completed2023-02-28Actual
Study of ATI-1777 in Patients 12 to 65 Years Old With Mild to Severe Atopic DermatitisNCT05432596ACRSPhase 2Completed2023-10-26Actual
A Study of the KIO-201 (Ocular Bandage Gel) for Improving Persistent Corneal Epithelial DefectsNCT05436288KPRXPhase 2Completed2022-12-22Actual
Topical SGX302 for Mild-to-Moderate PsoriasisNCT05442190SoligenixPhase 2Completed2025-10-22Actual
A Phase 3, Open-Label Extension of COURAGE-ALS (CY 5031)NCT05442775CytokineticsPhase 3Terminated2023-06-07Actual
A Study of ELX-02 in Patients With Alport SyndromeNCT05448755ELOXPhase 2Completed2023-09-11Actual
Berotralstat Treatment in Children With Hereditary AngioedemaNCT05453968BioCryst PharmaceuticalsPhase 3Active not recruiting2024-09-11Actual
Pilot Study Comparing the Safety and Efficacy of Two Dosing Regimens of TP-03 for the Treatment of MGDNCT05454956TARSPhase 2Completed2023-05-18Actual
A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung AdenocarcinomaNCT05456256LTRNPhase 2Recruiting2026-12Estimated
A Study to Evaluate the Safety and Efficacy of Rencofilstat in Adult Subjects With NASH F3NCT05461105Hepion Pharmaceuticals, Inc.Phase 2Completed2023-04-15Actual
SOLSTICE: Combination Therapy for the Treatment of Chronic Hepatitis D Infection.NCT05461170VIRPhase 2Active not recruiting2031-11Estimated
Study to Compare the Immunogenicity and Safety of 3 Lots of NVX-CoV2373 in AdultsNCT05463068NovavaxPhase 3Completed2022-08-17Actual
Investigate Efficacy, Safety, and Pharmacokinetics of Enzastaurin for the Prevention of Arterial Events in Patients With Vascular Ehlers-Danlos Syndrome.NCT05463679AYTUPhase 3Suspended2025-06Estimated
MN-001 in Non-alcoholic Fatty Liver Disease, Type 2 Diabetes Mellitus, and HypertriglyceridemiaNCT05464784MediciNovaPhase 2Active not recruiting2026-12-31Estimated
Study of AT-752 in Patients With Dengue InfectionNCT05466240AVIRPhase 2Terminated2023-01-19Actual
Phase 2a to Evaluate PL-8177 in Subjects with Active Ulcerative Colitis (UC)NCT05466890PTNPhase 2Active not recruiting2025-02-10Actual
Study to Evaluate Safety and Immunogenicity of COVID-19 Vaccine in Children 6 Months to < 12 YearsNCT05468736NovavaxPhase 2, Phase 3Completed2024-01-16Actual
A Study to Evaluate LB1148 for Return of Bowel Function in Subjects Undergoing Bowel ResectionNCT05470387Palisade BioPhase 3Terminated2023-03-06Actual
A Phase 2 Study to Evaluate the Efficacy and Safety of TNX-102 SL in Patients With Multi-Site Pain Associated With Post-Acute Sequelae of SARS-CoV-2 InfectionNCT05472090Tonix Pharmaceuticals, Inc.Phase 2Completed2023-07-12Actual
A Study Evaluating the Effect of Filgotinib Dose De-escalation in Participants With Ulcerative Colitis (UC) in RemissionNCT05479058LKFTPhase 3Terminated2023-10-09Actual
Efficacy and Safety of COMP360 Psilocybin Therapy in Anorexia Nervosa: a Proof-of-concept StudyNCT05481736COMPASS PathwaysPhase 2Completed2024-11-18Actual
A Study of Vatiquinone for the Treatment of Participants With Friedreich AtaxiaNCT05485987PTC TherapeuticsPhase 2Completed2024-08-29Actual
A Study of Tebapivat (AG-946) in Participants With Anemia Due to Lower-Risk Myelodysplastic Syndromes (LR-MDS)NCT05490446AGIOPhase 2Active not recruiting2026-03-17Actual
Ampligen Combined With SOC Versus SOC Alone Following First-Line Therapy in Subjects With LAPCNCT05494697AIMPhase 2Suspended2031-02Estimated

Primary completion marks the end of data collection for the main study measures, not a results publication date.